Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:11 pm Sale | 2021-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 3,282,912 10.720% | -166,000 (-4.81%) | Filing History |
| 2022-02-11 4:11 pm Sale | 2021-12-31 | 13G | WEREWOLF THERAPEUTICS INC HOWL | Flynn James E | 958,125 3.470% | -1,594,662 (-62.47%) | Filing History |
| 2022-02-11 4:10 pm Purchase | 2021-12-31 | 13G | PULMONX CORP LUNG | Flynn James E | 2,366,867 6.420% | 415,980 (+21.32%) | Filing History |
| 2022-02-11 4:10 pm Sale | 2021-12-31 | 13G | IVERIC BIO INC ISEE | Flynn James E | 4,761,138 4.150% | -1,006,271 (-17.45%) | Filing History |
| 2022-02-11 4:10 pm Purchase | 2021-12-31 | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | Flynn James E | 5,580,456 9.540% | 1,376,556 (+32.74%) | Filing History |
| 2022-02-11 4:09 pm Unchanged | 2021-12-31 | 13G | ESPERION THERAPEUTICS INC ESPR | Flynn James E | 10,000,000 8.060% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:09 pm Sale | 2021-12-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Flynn James E | 1,175,131 4.800% | -630,906 (-34.93%) | Filing History |
| 2022-02-11 4:08 pm Purchase | 2021-12-31 | 13G | ADAPTHEALTH CORP AHCO | Flynn James E | 24,272,428 7.720% | 2,871,653 (+13.42%) | Filing History |
| 2022-02-11 4:08 pm Purchase | 2021-12-31 | 13G | AERIE PHARMACEUTICALS INC AERI | Flynn James E | 4,695,020 9.910% | 2,159,519 (+85.17%) | Filing History |
| 2022-02-08 1:33 pm Sale | 2021-12-31 | 13G | BROOKDALE SENIOR LIVING INC CO BKD | Flynn James E | 4,274,808 2.310% | -6,748,657 (-61.22%) | Filing History |
| 2022-01-24 4:43 pm Purchase | 2022-01-13 | 13G | SILK RD MED INC SILK | Flynn James E | 1,861,917 5.340% | 1,861,917 (New Position) | Filing History |
| 2021-12-07 5:19 pm Purchase | 2021-12-07 | 13G | ESPERION THERAPEUTICS INC ESPR | Flynn James E | 10,000,000 8.170% | 10,000,000 (New Position) | Filing History |
| 2021-12-03 3:07 pm Purchase | 2021-11-29 | 13G | KURA ONCOLOGY INC KURA | Flynn James E | 3,513,756 5.280% | 3,513,756 (New Position) | Filing History |
| 2021-11-19 5:19 pm Purchase | 2021-11-12 | 13D | DFP HEALTHCARE ACQUISITIONS CO DFPH | Flynn James E | 24,074,650 4.900% | 13,614,650 (+130.16%) | Filing History |
| 2021-11-10 4:59 pm Purchase | 2021-11-05 | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | Flynn James E | 4,203,900 7.190% | 4,203,900 (New Position) | Filing History |
| 2021-10-26 7:35 pm Purchase | 2021-10-26 | 13G | XILIO THERAPEUTICS INC XLO | Flynn James E | 163,425 8.580% | 163,425 (New Position) | Filing History |
| 2021-09-28 11:29 am Purchase | 2021-09-20 | 13G | VINCERX PHARMA, INC VINC | Flynn James E | 68,966 6.560% | 68,966 (New Position) | Filing History |
| 2021-08-26 4:20 pm Purchase | 2021-08-23 | 13D | ACUTUS MED INC AFIB | Flynn James E | 5,852,924 9.500% | 345 (+0.01%) | Filing History |
| 2021-08-16 5:06 pm Purchase | 2021-08-04 | 13G | AERIE PHARMACEUTICALS INC AERI | Flynn James E | 2,535,501 5.370% | 2,041,285 (+413.03%) | Filing History |
| 2021-08-05 4:45 pm Purchase | 2021-07-26 | 13G | APRIA INC APR | Flynn James E | 2,431,417 6.900% | 2,431,417 (New Position) | Filing History |